Cargando…

The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats

BACKGROUND: ErXian decoction is a Chinese herbal compound that can prevent and control the course of osteoarthritis (OA) and osteoporosis (OP). OP and OA are two age-related diseases that often coexist in elderly individuals, and both are associated with dysregulation of the gut microbiome. In the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jie, Lishi, Ma, Zhenyuan, Gao, Yifan, Shi, Xiaoqing, Yu, Likai, Mao, Jun, Wang, Peimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159182/
https://www.ncbi.nlm.nih.gov/pubmed/37153081
http://dx.doi.org/10.3389/fmed.2023.1153360
_version_ 1785037080561188864
author Jie, Lishi
Ma, Zhenyuan
Gao, Yifan
Shi, Xiaoqing
Yu, Likai
Mao, Jun
Wang, Peimin
author_facet Jie, Lishi
Ma, Zhenyuan
Gao, Yifan
Shi, Xiaoqing
Yu, Likai
Mao, Jun
Wang, Peimin
author_sort Jie, Lishi
collection PubMed
description BACKGROUND: ErXian decoction is a Chinese herbal compound that can prevent and control the course of osteoarthritis (OA) and osteoporosis (OP). OP and OA are two age-related diseases that often coexist in elderly individuals, and both are associated with dysregulation of the gut microbiome. In the initial study, Palmatine (PAL) was obtained by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and network pharmacological screening techniques, followed by 16S rRNA sequencing and serum metabolomics of intestinal contents, to explore the mechanism of PAL in the treatment of OA and OP. METHODS: The rats selected for this study were randomly divided into three groups: a sham group, an OA-OP group and a PAL group. The sham group was intragastrically administered normal saline solution, and the PLA group was treated with PAL for 56 days. Through microcomputed tomography (micro-CT), ELISA, 16S rRNA gene sequencing and non-targeted metabonomics research, we explored the potential mechanism of intestinal microbiota and serum metabolites in PAL treatment of OA-OP rats. RESULTS: Palmatine significantly repair bone microarchitecture of rat femur in OA-OP rats and improved cartilage damage. The analysis of intestinal microflora showed that PAL could also improve the intestinal microflora disorder of OA-OP rats. For example, the abundance of Firmicutes, Bacteroidota, Actinobacteria, Lactobacillus, unclassified_f_Lachnospiraceae, norank_f_Muribaculaceae, Lactobacillaceae, Lachnospiraceae and Muribaculaceae increased after PAL intervention. In addition, the results of metabolomics data analysis showed that PAL also change the metabolic status of OA-OP rats. After PAL intervention, metabolites such as 5-methoxytryptophol, 2-methoxy acetaminophen sulfate, beta-tyrosine, indole-3-carboxylic acid-O-sulfate and cyclodopa glucoside increased. Association analysis of metabolomics and gut microbiota (GM) showed that the communication of multiple flora and different metabolites played an important role in OP and OA. CONCLUSION: Palmatine can improve cartilage degeneration and bone loss in OA-OP rats. The evidence we provided supports the idea that PAL improves OA-OP by altering GM and serum metabolites. In addition, the application of GM and serum metabolomics correlation analysis provides a new strategy for uncovering the mechanism of herbal treatment for bone diseases.
format Online
Article
Text
id pubmed-10159182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101591822023-05-05 The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats Jie, Lishi Ma, Zhenyuan Gao, Yifan Shi, Xiaoqing Yu, Likai Mao, Jun Wang, Peimin Front Med (Lausanne) Medicine BACKGROUND: ErXian decoction is a Chinese herbal compound that can prevent and control the course of osteoarthritis (OA) and osteoporosis (OP). OP and OA are two age-related diseases that often coexist in elderly individuals, and both are associated with dysregulation of the gut microbiome. In the initial study, Palmatine (PAL) was obtained by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and network pharmacological screening techniques, followed by 16S rRNA sequencing and serum metabolomics of intestinal contents, to explore the mechanism of PAL in the treatment of OA and OP. METHODS: The rats selected for this study were randomly divided into three groups: a sham group, an OA-OP group and a PAL group. The sham group was intragastrically administered normal saline solution, and the PLA group was treated with PAL for 56 days. Through microcomputed tomography (micro-CT), ELISA, 16S rRNA gene sequencing and non-targeted metabonomics research, we explored the potential mechanism of intestinal microbiota and serum metabolites in PAL treatment of OA-OP rats. RESULTS: Palmatine significantly repair bone microarchitecture of rat femur in OA-OP rats and improved cartilage damage. The analysis of intestinal microflora showed that PAL could also improve the intestinal microflora disorder of OA-OP rats. For example, the abundance of Firmicutes, Bacteroidota, Actinobacteria, Lactobacillus, unclassified_f_Lachnospiraceae, norank_f_Muribaculaceae, Lactobacillaceae, Lachnospiraceae and Muribaculaceae increased after PAL intervention. In addition, the results of metabolomics data analysis showed that PAL also change the metabolic status of OA-OP rats. After PAL intervention, metabolites such as 5-methoxytryptophol, 2-methoxy acetaminophen sulfate, beta-tyrosine, indole-3-carboxylic acid-O-sulfate and cyclodopa glucoside increased. Association analysis of metabolomics and gut microbiota (GM) showed that the communication of multiple flora and different metabolites played an important role in OP and OA. CONCLUSION: Palmatine can improve cartilage degeneration and bone loss in OA-OP rats. The evidence we provided supports the idea that PAL improves OA-OP by altering GM and serum metabolites. In addition, the application of GM and serum metabolomics correlation analysis provides a new strategy for uncovering the mechanism of herbal treatment for bone diseases. Frontiers Media S.A. 2023-04-20 /pmc/articles/PMC10159182/ /pubmed/37153081 http://dx.doi.org/10.3389/fmed.2023.1153360 Text en Copyright © 2023 Jie, Ma, Gao, Shi, Yu, Mao and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jie, Lishi
Ma, Zhenyuan
Gao, Yifan
Shi, Xiaoqing
Yu, Likai
Mao, Jun
Wang, Peimin
The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats
title The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats
title_full The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats
title_fullStr The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats
title_full_unstemmed The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats
title_short The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats
title_sort mechanism of palmatine-mediated intestinal flora and host metabolism intervention in oa-op comorbidity rats
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159182/
https://www.ncbi.nlm.nih.gov/pubmed/37153081
http://dx.doi.org/10.3389/fmed.2023.1153360
work_keys_str_mv AT jielishi themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT mazhenyuan themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT gaoyifan themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT shixiaoqing themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT yulikai themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT maojun themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT wangpeimin themechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT jielishi mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT mazhenyuan mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT gaoyifan mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT shixiaoqing mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT yulikai mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT maojun mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats
AT wangpeimin mechanismofpalmatinemediatedintestinalfloraandhostmetabolisminterventioninoaopcomorbidityrats